Profilo
Motasim Sirhan currently works at Elixir Medical Corp., as Chief Executive Officer & Director and Apama Medical, Inc., as Director.
Posizioni attive di Motasim Sirhan
| Società | Posizione | Inizio |
|---|---|---|
Apama Medical, Inc.
 Apama Medical, Inc. Medical SpecialtiesHealth Technology Apama Medical, Inc. operates as a medical device company which focuses on the treatment of atrial fibrillation. The firm focuses on the electrophysiology market and offers a vastly superior catheter-based solution for the fastest growing market segment, atrial fibrillation ablation. The company was founded by Amr Salahieh in 2009 and is headquartered in Campbell, CA. | Direttore/Membro del Consiglio | - |
Elixir Medical Corp.
 Elixir Medical Corp. BiotechnologyHealth Technology Elixir Medical Corp. develops innovative products that combine state of the art medical devices with advanced pharmaceuticals. Its next-generation drug-eluting stent systems and bioresorbable coronary scaffold are designed to optimize localized drug delivery to provide safe and effective treatments for cardiovascular patients. The company was founded in 2005 and is headquartered in Sunnyvale, CA. | Amministratore Delegato | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Apama Medical, Inc.
Apama Medical, Inc. Medical SpecialtiesHealth Technology Apama Medical, Inc. operates as a medical device company which focuses on the treatment of atrial fibrillation. The firm focuses on the electrophysiology market and offers a vastly superior catheter-based solution for the fastest growing market segment, atrial fibrillation ablation. The company was founded by Amr Salahieh in 2009 and is headquartered in Campbell, CA. | Health Technology |
Elixir Medical Corp.
Elixir Medical Corp. BiotechnologyHealth Technology Elixir Medical Corp. develops innovative products that combine state of the art medical devices with advanced pharmaceuticals. Its next-generation drug-eluting stent systems and bioresorbable coronary scaffold are designed to optimize localized drug delivery to provide safe and effective treatments for cardiovascular patients. The company was founded in 2005 and is headquartered in Sunnyvale, CA. | Health Technology |
- Borsa valori
- Insiders
- Motasim Sirhan
